ICLR Icon Plc Services-Commercial Physical & Biological Research Best Diagnostics Stocks 2026 →

Icon (ICLR) Stock: Buy, Sell, or Hold?

$199.70
-4.93 (-2.41%) â–ŧ
5d: -1.68% 30d: +21.52% 90d: +19.24%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (55%)
Quality Score
31/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$167.60 – $203.98
Position: SLIGHTLY HIGH
Forward P/E & Valuation
17.2x STRETCHED
vs 12.4x historical avg
Wall Street Target
$231.29
+15.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$197.21 / $219.04
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: ICLR is fairly priced but lacks strong directional signals. At 11.5% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.

Get Alerted When ICLR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$199.28
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$123.74
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.4x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ICLR is currently trading at $199.70, which is considered slightly high relative to its 30-day fair value range of $167.60 to $203.98. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.2) compared to its historical average (12.4). At these levels, the market is pricing in 11.5% annual earnings growth.

Technical Outlook: Technically, ICLR is in a uptrend. The price is currently testing key support at $197.21. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: ICLR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $231.29 (+15.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $167.60 - $203.98
Company Quality Score 31/100 (SELL)
Volume Confirmation HIGH
Confidence Score 54.6%

Trading Range & Key Levels

30-Day Trading Range $167.60 - $203.98
Current vs Trading Range SLIGHTLY HIGH
Expected Move (7 Days) Âą$12.33 (6.2%)
Support Level $197.21
Resistance Level $219.04
Current Trend Uptrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding ICLR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Options cheap (IV 0th percentile)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($231.29)
  • BULLISH: Expecting earnings turnaround to 11.5% growth with -2.9% revenue growth
  • WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 17.21
Wall Street Target $231.29 (+15.8%)
Revenue Growth (YoY) -2.9%
Earnings Growth (YoY) -63.3%
Profit Margin 5.3%
Valuation Premium vs History +11.5% premium
PE vs Historical 17.2 vs 12.4 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +11.5% (market-implied from PE analysis)
1-Year Target $222.67 (+12%)
2-Year Target $248.27 (+24%)
3-Year Target $276.82 (+39%)
3-Yr Target (if PE normalizes) (PE: 17→12) PE COMPRESSION $199.44 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 9.5%) $302.81 (+52%)
Base: (SPY PE: 17.2, Growth: 9.5%) $262.43 (+31%)
Bear: (PE: 12.4, Growth: 9.5%) $189.07 (-5%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Forward PE: 18.25 | Forward EPS (Implied): $10.94
Bull Case $241.14 (+21%)
Analyst growth 15.0%, PE expands to 19.2
Base Case $199.70 (0%)
Market implied 0.0%, PE stable at 18.3
Bear Case $152.77 (-24%)
Severe decline -15.0%, PE contracts to 16.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share ICLR Analysis

Share this live ICLR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ICLR)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary: Icon PLC (ICLR) reported Q3 earnings of $2.66 per share, beating estimates, and revenue of $2.02 billion, surpassing consensus. The company has topped revenue estimates in the last three quarters.
Key Retail Themes: earnings beat revenue beat
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:09 AM ET
Data refreshes hourly during market hours. Next update: 4:09 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ICLR.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
GH
Guardant Health Inc
STRONG BUY
26 analysts
$201 51 HOLD
NTRA
Natera Inc
STRONG BUY
23 analysts
$416 65 BUY
EXAS
EXACT Sciences Corporatiâ€Ļ
STRONG BUY
26 analysts
$106 52 HOLD
TMO
Thermo Fisher Scientificâ€Ļ
STRONG BUY
27 analysts
$752 47 HOLD
DHR
Danaher Corporation
STRONG BUY
24 analysts
$260 51 HOLD

Advanced ICLR Option Strategies

Professional options setups generated by AI based on today's ICLR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ICLR Research Pages
ICLR Technical Chart ICLR Price Prediction ICLR Intrinsic Value DCF ICLR Earnings Date Why is ICLR Moving Today? ICLR Investment Advisor ICLR Fair Price Analyzer ICLR Options Chain ICLR Options Advisor ICLR Options Analysis ICLR Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals